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Our aim was to explore the thiol/disulphide homeostasis and the link with functional status in patients who have knee 
OA. Sixty knee OA patients and 50 healthy individuals were enrolled in this study. We measured serum levels of native 
thiol, total thiol and disulphide. In order to measure the alterations in functional status such tests as the Western Ontario, 
MacMaster Osteoarthitis index (WOMAC), walking test and Visual Analogue Scale (VAS) were utilized. The total thiol 
levels were higher in the control group than the knee OA patients (P< 0.05). Disulphide and disulphide/total thiol levels 
were significantly lower when control group were compared to knee OA patients (P< 0.05).Activity pain was negatively 
associated with native thiol levels (P< 0.05), walking test scores were negatively correlated with the native thiol levels 
(P< 0.05) and positively correlated with disulphide levels (P< 0.05) in knee OA patients. In knee OA patients, no 
correlation was observed between thiol/disulphide parameters and WOMAC scores. Conclusion, thiol/disulphide 
homeostasis is impaired in patients with knee osteoarthritis. Disulphide level increased and thiol level decreased due to 
oxidative stress. Thiol/ disulphide homeostasis had not noticeable impact on the on functional status. Thiol/disulphide 
homeostasis may help to explain the pathogenesis of osteoarthritis. 
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Osteoarthritis (OA) is a degenerative joint disease of 
unknown etiology that affects many different joints 
and, leads to disability in the population
1
. Most 
patients experience difficulties in their daily life 
activities and approximately one fourth have 
functional limitations, such as decreased joint motion, 
muscle atrophy and morning stiffness
2
. The 
pathogenesis of OA has not been completely 
understood yet, several genetic and environmental 
factors associated with the molecular pathway that 
contribute to the progression of the disease affect the 
pathogenesis of osteoarthritis
3
. Subchondral bone 
cartilage, synovial membrane, ligaments, and 
periarticular muscles are affected by OA. It is well 
known that articular cartilage changes play an 
important role in the development of OA
1
. 
.Irreversible deterioration of joint structure and 
cartilage loss leading to progressive deterioration are 
observed in OA pathogenesis
4
. Some patients with 
acute synovitis in OA have been found to have 
synovial proliferation and inflammatory changes
5
. In 
previous studies, reactive oxygen species (ROS) 
production has been suggested to increase in joint 
diseases such as OA and rheumatoid arthritis
6
. 
Thiols are a group compounds including sulfhydryl 
groups in their structures. The homeostasis 
of thiol/disulphide is one of the most important 
protection mechanisms opposite oxidative stress
7-9
. ROS 
is released into the area of inflammation along with 
proinflammatory factors in many joint diseases
10
. ROS 
has the capacity for oxidation and unfold proteins, 
playing role in the harmful effects of oxidative stress. 
Thiols due to oxidative stress may undergo an oxidation 
reaction to compose reversible disulphide bonds. Thus, 
dynamic thiol/disulphide balance status maintained
11
. 
Thiol disulphide homeostasis plays significant roles in 
antioxidant effect, apoptosis, signal transduction, 
detoxification, enzymatic activities and cellular signaling 
mechanisms
9,12
. In our study, our aim was to compare 
the thiol disulphide homeostasis of knee OA patients and 
healthy individuals and to explore the link with 
functional status in knee OA patients. 
Materials and Methods 
Study population 
Sixty knee OA patients and 50 healthy individuals 








College of Rheumatology criteria for knee OA, our 
study included OA patients
13
. Patients have grade 2 or 
3 degree knee osteoarthritis according to Kellgren and 
Lawrence criteria
14
. The knee OA patients received 
analgesic (paracetamol; 1500 mg/day) treatment.We 
got all participants’ specified histories and fulfilled 
systemic and rheumatologic examinations. Patients 
and healthy individuals with a history of chronic 
diseases (diabetes mellitus, hypertension, obesity, 
hyperlipidemia, depression, autoimmune disease), 
alcohol and cigarette consumption, steroids and 
immunosuppressive drugs use for the last four weeks, 
the presence of available infections and regular 
vitamin medication were excluded. This study design 
was approved by The Recep Tayyip Erdogan 
University Research Ethics Committee and informed 
consent was provided by all participants. 
 
Measurement procedures 
By the method defined by Erel and Neselioglu
15
, 
plasma total thiol, native thiol, and disulphide levels 
of all patients and volunteers were measured and then 
we assessed thiol/disulphide homeostasis. In this 
method initially, the thiol level in plasma was 
measured without pretreatment. This first result was 
regarded as native thiol. Next, a pretreatment process 
was performed using sodium borohydrate to reduce 
the dynamic disulfide bonds to free sulfhydryl groups. 
The result obtained was considered to be the total 
thiol. Finally, the disulphide level was considered half 
the difference between total thioland native thiol. We 
gathered the 5 mL blood samples of venous into SST 
tubes (BD Vacutainer SST II Advance, USA). To 
acquire sera blood tubes were centrifuged 10 min at 
1000 × g. Until the assessment was performed, 
samples were kept at − 20°C. Total thiol, native thiol 
serum, and disulphide levels were measured by a new 
automated method defined by Erel and Neselioglu. By 
using a Cobas c501 chemical analyzer (Roche 
Diagnostics, Mannheinu Germany), we carried 
outcome measurements. After measuring total thiols 
(SH+SS), native (SH), and disulphide levels (SS), 
native thiol/total thiol percent ratios (SH/SH+SS), 
disulphide/total thiol percent ratios (SS/SH+SS), and 
disulphide /native thiol percent ratios (SS/SH) were 
computed by multiplying with 100. Through the use 
of Visual Analog Scale (VAS), pain levels at rest and 
at activity was measured
16
. By utilizing a 0 to  
10 visual analogue pain scale, with 0 meaning 'no 
pain' and 10 meaning 'unbearable pain', pain was 
assessed. It is a scale where each centimeter is given 
numerical value with an interval of one centimeter. In 
the Western Ontario and MacMaster osteoarthritis 
index (WOMAC), 24 elements isolated into  
3 subscales (pain, stiffness, and physical function 
scales) were combined. The maximum scores that can 
be obtained from the index are 20 for pain subgroup, 
8 for stiffness subgroup, 68 for physical function 
subgroup. High scores indicate increased pain and 
stiffness and impaired physical function. So as to 
assess the functional status, WOMAC, a dependable 
index for use in Turkish patients who have knee 
osteoarthritis and standing-up from a chair and 15 






The SPSS for Windows 18.0 software package 
(IBM Corporation, Armonk, USA) was employedso 
as to assess the statistical data. The Kolmogorov-
Smirnov test was used to assess the normality of the 
distributions of variables. Study results were 
demonstrated as mean±standard deviation. Student's  
t-test was utilized to compare normally distributed 
numerical variables. The Mann-Whitney U-test was 
utilized to compare abnormally distributed numerical 
variables. The chi-square test was utilized to compare 
the study groups in terms of gender distribution. 
Pearson correlation test was utilized to evaluate the 
relationship between normally distributed numerical 
variables. Spearman correlation test was utilized  
to evaluate the relationship between abnormally 
distributed numerical variables. Statistically 
significant P values were less than 0.05. 
 
Results 
In Table 1, the parameters of laboratory and the 
clinical properties of the knee OA patients and control 
group have been shown. In demographic 
characteristics of the study groups, no significant 
differences were detected (P> 0.05). In the knee OA 
patients, the mean age was 64.23 ± 8.37 years and 
62.10 ± 6.63 years in the control group. In patients 
with knee OA, it was observed that the disease 
duration was 5.78 ±3.89 years. When they were 
compared to control group, in disulphide (P< 0.05) 
and disulphide/total thiol levels (P< 0.05) in patients 
with knee OA, statistically significant differences 
were observed. In disulphide/native thiol levels of the 
study groups, no meaningful diffrences were 
discovered, yet the levels of disulphide/native thiol 
for the patients with knee were higher than the control 




group. When they were compared to patients with 
knee OA, in native thiol and native/total thiol levels in 
control group, statistically significant differences 
were seen (P<0.05, respectively). It was found that 
there were no significant differences in total thiol 
levels of the study groups, though total thiol levels of 
the control group were higher than patients with knee 
OA (Table 2 & Fig. 1A-C).  
Activity pain negative was associated with native 
thiol levels (r = − 0.30. P = 0.01). In patients with 
knee OA, the disease duration was negatively 
associated with native thiol and total thiol levels  
(r = − 0.30, P = 0.01; r = − 0.39, P = 0.00, 
respectively). A negative relationship between 
walking test scores and the serum native thiol levels 
and a positive association between the walking test 
scores and serum disulphide levels in knee OA 
patients (r = − 0.37, P = 0.00; r = 0.33. P = 0.00, 
respectively). In patients with knee OA, no correlation 
between serum thiol/ disulphide results and erythrocyte 
sedimentation rate (ESR), C-reactive protein (CRP), 
WOMAC scores was observed (Table 3). 
Table 1 — Demographic characteristics of the study groups 
Variables Patient group  
(n=60) Mean± SD 
Control group  




64.23 ± 8.37 
 
62.10 ± 6.63 
Gender 
Women, n (%) 







BMI 28.15 ± 2.21 27.43 ± 2.16 
Disease duration (years) 5.78 ± 3.89 - 
Walking test (seconds) 14.62 ± 3.31 - 
VAS (rest pain) 
VAS (activity pain) 
2.91 ± 1.14 
6.05 ± 1.34 
- 
- 
ESR (mm/s) 17.13 ± 11.06 - 
CRP (mg/L) 0.5 ± 0.36 - 
WOMAC pain 
WOMAC stiffness score 
WOMAC physical 
function 
9.55 ± 2.89 
3.46 ± 1.15 




SD; standard deviation, BMI; body mass index, ESR; erythrocyte 
sedimentation rate, CRP; C - reactive protein, *Statistically 
significant difference ;  P< 0.05 
 
 
Table 2 — Plasma thiol-disulphide levels of patient  
and control group 









Native thiol, μ mol/L  
 
332.42 ± 39.68 
 
359.50 ± 96.06 
 
0.04 
Total thiol, μ mol/L 382.31 ± 43.42 396.86 ± 94.41 0.28 
Native/total thiol, %  87.07 ± 5.98 89.77 ± 6.48 0.02 
Disulphide, μ mol/L 24.94 ± 12.47 18.71 ± 7.94 0.00 
Disulphide/native thiol, % 7.71 ± 4.27 6.01 ± 4.93 0.05 
Disulphide/total thiol, %  6.46 ± 2.99 5.09 ± 3.21 0.02 
SD; standard deviation 
 
 
Fig. 1 — (A) Serum native thiol; (B) Serum total thiol; and  
(C) Serum disulphide levels in patients with knee osteoarthritis 
and control 





Along with proinflammatory factors like cytokines 
and prostaglandins, in many of joint diseases, ROS 
and nitric oxide are released at the inflammation 
regions
10
. ROS production is displayed to raise in 
joint diseases like rheumatoid arthritis and 
osteoarthritis
6
. Moreover, increased oxidative stress in 
atheroselerosis, diabetes mellitus, neurodegenerative 
syndromes, and systemic sclerosis were demonstrated 
in earlier studies
19-21
. It was suggested by Tetik et al. 
that plasma proteins are sensitive to oxidative stress in 
osteoarthritis, an inflammatory disease and thus 
oxidative stress increase may be the reason of disease 
severity. Additionally, it was stated that OA patients 
are at risk of significant tissue oxidant damage on 
account of impaired antioxidant defense
22
. 
OA is a chronic inflammatory disease caused by 
gradual changes in the immune system
23
. It has been 
recommended by recent studies that OA development 
is signifîcantly linked with oxidative stress and 
ROS
24,25
. ROS contributes to the loss of chondrocyte 
sensibility to growth factors
26
. The overproduction of 
ROS contributes to cartilage destruction, and 
chondrocytes and collagens are highly sensitive to the 
cumulative effects of oxidative stress
27
. Oxidative 
damage has an adverse effect on the collagen
28
. ROS 
may also attend in the failure of repair by decreasing 
the capacity of chondrogenic precursor cells to 
migrate and proliferate within a damaged field
29
. 
Damage to proteins due to oxidant accumulation 
causes changes in mechanical damage and the water-
holding capacity of collagen fibrils
30
. Oxidative stress 
has a significant role in chondrocyte apoptosis
31
. 
Studies show that oxidative stress causes chondrocyte 
senescence and cartilage ageing
32,33
. Altı ndag et al. 
found that plasma thiol level considerably decreased 
in OA patients compared to healthy controls. 
Furthermore, they indicated that decreasing collagen 
metabolism may be associated with oxidative stress and 
oxidative stress may have an effect on pathogenesis 
Table 3 — The relationship between plasma thiol-disulphide levels and other variables in patient group 
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SD; standard deviation, BMI; body mass index, ESR; erythrocyte sedimentation rate, CRP; C - reactive protein,  
*Statistically significant difference ;  P< 0.05 






. El-barbary et al. suggested 
that oxidative stress level elevated in OA patients and 
oxidative stress has a role on the pathogenesis of 
OA
35
. Soran et al. stated that oxidative stress elevated 
in knee OA patients
36
. In this research, we showed the 
thiol level, which was known as an significant 
ingredient of the plasma antioxidant system, was  
less in knee OA patients than the control group. We 
found that disulphide/native thiol, disulphide, and 
disulphide/total thiol ratios were higher in knee OA 
patients than control group, while total thiol, native 
thiol, and native/total thiol levels were lower. Since 
ROS cause disulfide bonds by oxidation of thiol 
groups of sulfur-containing amino acids in proteins, 
total thiol levels of the patients with knee OA  
were lower than the control group. The 
thiol/disulphide equilibrium was determined to be 
weaker in knee OA patients than the control group 
and the balance altered towards disulphide formation. 
This indicates that the level of oxidative stress  
is higher in with the knee OA patients than in  
the control group. The outcomes we obtained were 
compatible with the previous studies in the literature. 
We believe that the impairment of plasma antioxidant 
defense is an important risk factor for tissue  
oxidant damage in patients with OA. Future  
studies with large patient populations might help  
to elucidate the mechanisms of the association  
of thiol/disulphide homeostasis with OA in the 
antioxidant defense.  
The most widespread chronic diseases causing to 
physical disablement and pain in patients is OA
37
. OA 
is frequently related with functional limitation  
and impaired quality of life
38
. Dogru et al. showed a 
significant negative association between the VAS  
and the plasma thiol levels in ankylosing spondylitis 
patients
39
. In this study, we determined a statistically 
significant negative relationship between the VAS 
and the plasma native thiol concentrations and disease 
duration. Moreover, we found a significant 
relationship between thiol homeostasis and walking 
test scores in knee OA patients. Nevertheless, no 
relation was seen between the thiol/disulphide 
homeostasis outcomes and WOMAC subscales. 
There were some limitations in our research. 
Firstly, the study population was small sample size in 
our study. Secondly, patients in our study were not 
followed for a long time. A larger study population 
with long-term patient follow-up may provide 
stronger statistical data. 
Conclusion 
The outcomes of this research demonstrated that in 
knee OA, oxidative stress is increased, yet thiol/ 
disulphide homeostasis had not noticeable impact on 
the on functional status. Thiol/disulfide homeostasis 
may be an important parameter to elucidate the effects 
of oxidative stress. We think that the role of 
thiol/disulphide homeostasis on oxidative stress in 
OA should be investigated by future studies and this 
may also help to evaluate the role of oxidative stress 
on etiopathogenesis of OA. 
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